A STUDY TO ASSESS THE EFFECTIVENESS OF CAP ASMO IN COVID 19 POSITIVE CASES
Phase 2
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/12/029714
- Lead Sponsor
- RPS BIOTECH PVT LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. RT-PCR Based Corona positive patient OR RAPID ANTIGEN TEST
2. Consent to participate in the trial
Exclusion Criteria
1. Individual with uncontrolled unstable comorbidities
2. Individual with pre- existing respiratory conditions
3. Immunocompromised individuals or those on
immunosuppressants
4. Patients on or requiring parenteral nutrition
5. Pregnant and lactating female
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Improvement in Bala of an individual <br/ ><br>2. Immuno- stimulation leading to <br/ ><br>non-development of Covid-19 in risk population <br/ ><br>exposed to infected individual <br/ ><br>Timepoint: ASSESSMENT AFTER 1 WEEK <br/ ><br>1. Improvement in Bala of an individual <br/ ><br>2. Immuno- stimulation leading to <br/ ><br>non-development of Covid-19 in risk population <br/ ><br>exposed to infected individual <br/ ><br>
- Secondary Outcome Measures
Name Time Method IMPROVEMENT IN QUALITY OF LIFETimepoint: ASSESSMENT AFTER 4 WEEKS IMPROVEMENT IN QUALITY OF LIFE